Long Ideas - Depomed Inc. (NASDAQ:DEPO) announced last night that it has submitted a New Drug Application to the FDA for Serada, the company’s extended release formulation of … Continue Reading
Read nowLong Ideas - An announcement this morning from MAP Pharmaceuticals (NASDAQ:MAPP) said that the company will be offering nearly 4 million shares of the company’s common stock at … Continue Reading
Read now- Life Technology’s (NASDAQ:LIFE) second quarter’s earnings miss was disappointing, with the company reporting adjusted earnings per share of $0.96 and revenues of $949 million, versus … Continue Reading
Read nowLong Ideas - Idenix Pharmaceuticals (NASDAQ:IDIX) announced Tuesday morning that the company will be restructuring its partnership strategy with Novartis (NYSE:NVS). The announcement nullifies licensing of Tyzeka (IDIX’s … Continue Reading
Read now- Array BioPHarma (NASDAQ:ARRY) announced that its novel treatment for pain, ARRY-797, met its primary endpoint in a Phase 2 clinical trial, however, safety issues are … Continue Reading
Read now- At least three analysts have downgraded Auxilium Pharmaceuticals (NASDAQ:AUXL) this morning after the company reported strong second quarter earnings yesterday, with the stock approaching its … Continue Reading
Read nowLong Ideas - Shares of Horizon Pharmaceuticals (NASDAQ:HZNP) have traded down 25% since the FDA’s approval of Rayos, the company’s delayed-release arthritis drug, last Thursday. As with most … Continue Reading
Read now